comparemela.com

Latest Breaking News On - Dk novo b - Page 15 : comparemela.com

Novo Nordisk says Wegovy reduced risk of adverse cardiovascular events by 20% in adults with obesity in trial

Wegovy s success in reducing cardio risk is an important win, and a best-case scenario, say Wolfe analysts

The success of Novo Nordisk’s Wegovy in reducing cardiovascular events in obese adults is an important win for the obesity category with positive.

vimarsana © 2020. All Rights Reserved.